Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Beijing Tongrentang Research Institute is the core research and development division of the China Beijing Tongrentang Group, a historic leader in the Traditional Chinese Medicine (TCM) industry. The institute is dedicated to the modernization of TCM through rigorous scientific validation, quality standardization, and the development of innovative herbal formulations. Its research portfolio encompasses a wide range of therapeutic areas, including cardiovascular health, neurology, and metabolic diseases, often focusing on the secondary development of classic ancient formulas. By integrating advanced analytical technologies like network pharmacology and TCM fingerprinting, the institute ensures that traditional therapies meet modern global pharmaceutical requirements. It serves as a vital link between the company's 350-year heritage and the future of evidence-based natural medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Institute of Beijing Tongrentang.